BSE filing, NSE: BEDMUTHA. Summary written from the filing by ALFA Finder's alert engine.
Bedmutha Industries Ltd: key numbers
- Share price
- ₹106.50
- Market cap
- ₹343.6 Cr
- Revenue (annual)
- ₹1,467 Cr
- Net profit (annual)
- ₹6.50 Cr
- P/E (TTM)
- 20.5×Sector 16.7×
- Promoter holding
- 57.09%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Bedmutha Industries Ltd
All →Bedmutha Industries Other Announcement
Bedmutha Industries Ltd has submitted its quarterly shareholding pattern for the period ending September 30, 2026, as per SEBI regulations.
Bedmutha Industries Annual General Meeting
Bedmutha Industries Limited held its 36th Annual General Meeting on September 28, 2026. Shareholders considered financial statement adoption, director re-appointments, and related party transactions.
Bedmutha Industries Capital Structure Change
S.R. Foundation and others acquired 8,763 shares of Bedmutha Industries Ltd, increasing their total stake to 5.02%. This non-promoter acquisition was disclosed per SAST regulations.
Bedmutha Industries Other Announcement
Bedmutha Industries shared a link for accessing its Annual Report and AGM Notice with shareholders whose email IDs are not registered.
Bedmutha Industries Annual Report
Bedmutha Industries Ltd has filed its Annual Report for the financial year ended March 31, 2026, as required under SEBI Listing Regulations.
Bedmutha Industries Annual General Meeting
Bedmutha Industries Limited issued notice for its 36th Annual General Meeting scheduled for September 28, 2026. Shareholders will consider financial statements and related party transactions.
Other board meeting date announcements
All →HCP Plastene Bulkpack Board Meeting Date
HCP Plastene Bulkpack scheduled a board meeting for 06 November 2026. It will consider unaudited results for the quarter and half year ending 30 September 2026.
Ultracab (India) Board Meeting Date
Ultracab (India) Ltd intimated that its Board meeting is scheduled for 04-Nov-2026 to consider unaudited standalone financial results. No results or financial figures are disclosed in this advance notice.
Texmaco Infrastructure & Holdings Board Meeting Date
Texmaco has scheduled a Board meeting on November 5, 2026, to approve Q2 and H2 FY27 financial results. Trading window stays closed for insiders pending results declaration.
Astonea Labs Board Meeting Date
Astonea Labs intimated that its Board is scheduled on 14 Nov 2026 to consider unaudited half-year results. The trading window remains closed until 48 hours post-announcement.
AstraZeneca Pharma India Board Meeting Date
AstraZeneca Pharma India scheduled its board meeting for 5 Nov 2026 to approve Q2/H1 FY27 results. The trading window remains closed until 7 Nov 2026.
Mafatlal Industries Board Meeting Date
Mafatlal Industries updated that its 4 November 2026 board meeting will consider an interim dividend for FY27. Record date, if approved, is 13 November 2026.